"What I don’t understand is how there hasn’t b
Post# of 145524
![Avatar](/images/ProfileImages/167738657_59587_mando klein.jpg)
That happens when you over-enroll open-label, non-randomized studies by 300% or more, and fail to conduct appropriate studies...
FDA should have asked to stop enrollment in those trials (similar to what they did with our eINDs) and asked for double-blind, placebo-controlled studies...
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)